Figure 2.
Baseline NIH cGVHD organ-specific scores and global stage. The majority of subjects (97%) had skin and joint/fascia involvement, with all but one (97%) having moderate to severe skin and 74% moderate to severe joint/fascia cGVHD. Lungs, mouth, gastrointestinal (GI) tract, and liver were involved in 82%, 71%, 44%, and 38% of subjects, respectively, without any subject having severe organ-specific cGVHD in these organs. Eye involvement was present in 71% of subjects, with approximately one-third having severe ocular cGVHD. Ten of 12 female subjects had genital involvement (GYN). Distribution of organ-specific cGVHD was similar between the LD and HD cohorts.

Baseline NIH cGVHD organ-specific scores and global stage. The majority of subjects (97%) had skin and joint/fascia involvement, with all but one (97%) having moderate to severe skin and 74% moderate to severe joint/fascia cGVHD. Lungs, mouth, gastrointestinal (GI) tract, and liver were involved in 82%, 71%, 44%, and 38% of subjects, respectively, without any subject having severe organ-specific cGVHD in these organs. Eye involvement was present in 71% of subjects, with approximately one-third having severe ocular cGVHD. Ten of 12 female subjects had genital involvement (GYN). Distribution of organ-specific cGVHD was similar between the LD and HD cohorts.

Close Modal

or Create an Account

Close Modal
Close Modal